Journal List > J Korean Soc Menopause > v.19(2) > 1052096

TOOLS
Chung, Kim, Lee, Park, and Sang: Hormone Therapy in Postmenopausal Women According to the Correlation of Changes in Bone Mineral Density
Original Article

The Journal of Korean Society of Menopause 2013; 19(2): 101-105.

Published online: 27 August 2013

DOI: https://doi.org/10.6118/jksm.2013.19.2.101

Hormone Therapy in Postmenopausal Women According to the Correlation of Changes in Bone Mineral Density

Soo-Ho Chung, M.D.1, Tae-Hee Kim, M.D., Ph.D.1, Hae-Hyeog Lee, M.D., Ph.D.1, Junsik Park, M.D.1, Jae-Hong Sang, M.D.2

1Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

2Department of Obstetrics and Gynecology, College of Medicine, Soonchunhyang University Gumi Hospital, Gumi, Korea.

Address for Correspondence: Jae-Hong Sang, Department of Obstetrics and Gynecology, Soonchunhyang University Gumi Hospital, Gongdan 2-dong, Gumi 730-706, Korea. Tel: +82-54-468-9214, Fax: +82-54-468-7504, thorsang@hanafos.com

Received 6 June 2013       Revised 26 June 2013       Accepted 27 June 2013

Copyright © 2013 by The Korean Society of Menopause

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).

Abstract

Objectives

We investigated the relationship between bone mineral density (BMD) and hormone therapy (HT) and its duration in postmenopausal women.

Methods

We performed a retrospective study on 291 postmenopausal women who had their BMD and follow-up BMD measured in a university hospital. We analyzed BMD, HT types and HT duration according to clinical characteristics.

Results

The mean age of the study subjects was 53.7 ± 5.9 years. HT types and HT duration were not statistically related to improvement in BMD (P = 0.956, 0.483). But osteoporosis in patients with hormone therapy improves bone mineral density showed statistical significance (P = 0.001).

Conclusion

HT types and HT duration did not have any effect on bone mineral density, but further prospective multicenter studies regarding HT should be considered for osteoporosis.

Keywords: Bone mineral density, Hormone therapy, Osteoporosis

Figures and Tables

Table 1
Demographic and clinical characteristics of patients
jksm-19-101-i001

SD: mean standard deviation, HT: hormone therapy, F/U: follow-up, BMD: bone mineral density

Table 2
Bone mineral density changes according to hormone therapy type
jksm-19-101-i002

BMD: bone mineral density

Table 3
Bone mineral density changes according to osteoporosis status
jksm-19-101-i003

BMD: bone mineral density

References

1. Lee JK, Kim EJ, Suk MH, Kim EY, Hwang LI. Factors influencing osteoporosis. J Korean Community Nurs. 2003; 14:253–262.
2. Hall JW 3rd, Kennedy BJ. Idiopathic osteoporosis. Arch Intern Med. 1961; 108:448–455.
3. Kanis JA. WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int. 1994; 4:368–381.
4. National Institutes of Health. Osteoporosis. Conn Med. 1984; 48:651–655.
5. Wang XD, Masilamani NS, Mabrey JD, Alder ME, Agrawal CM. Changes in the fracture toughness of bone may not be reflected in its mineral density, porosity, and tensile properties. Bone. 1998; 23:67–72.
6. Anderson JJ. The role of nutrition in the functioning of skeletal tissue. Nutr Rev. 1992; 50:388–394.
7. Kim TH, Lee HH, Chung SH, Park HS. Differentiation in the management of osteoporosis between premenopausal and menopausal women. J Korean Soc Menopause. 2011; 17:21–26.
8. Kim JG, No JH, Hong JS, Kim SH, Choi YM, Moon SY, et al. A study on risk factors for postmenopausal osteoporosis. Korean J Obstet Gynecol. 2001; 44:1621–1626.
9. Park HM, So JS. The validational study of OSTA (Osteoporosis Self Assessment Tool for Asian) for prediction of osteoporosis in Korean post- and perimenopausal women. Korean J Obstet Gynecol. 2003; 46:276–282.
10. Cho SH, Cho SH, Kim KT, Hwang YY, Lee JA, Cho SS. Variations in spinal bone mineral density after one year of hormone replacement therapy in postmenopausal women. Korean J Obstet Gynecol. 1994; 37:1584–1590.
11. Kim JG, Ku SY, Jee BC, Suh CS, Kim SH, Choi YM, et al. The relationship between osteoprotegerin (OPG)-receptor activator of NF-kB ligand (RANKL) gene polymorphisms and change in bone mineral density after hormone therapy in postmenopausal Korean women. Korean J Obstet Gynecol. 2007; 50:901–911.
12. Chung YS. The medical treatment of osteoporosis. Korean J Med. 2010; 79:250–253.
TOOLS
Similar articles